Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.
Open Access
- 1 December 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (6), 2783-2789
- https://doi.org/10.1172/jci116897
Abstract
Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degradation in gastrocnemius muscle, heart, and liver, while fractional synthesis rates were similar to those in non-tumor bearing rats. This hypercatabolic pattern was associated with marked perturbations of the hormonal homeostasis and presence of tumor necrosis factor in the circulation. The daily administration of a goat anti-murine TNF IgG to tumor-bearing rats decreased protein degradation rates in skeletal muscle, heart, and liver as compared with tumor-bearing rats receiving a nonimmune goat IgG. The anti-TNF treatment was also effective in attenuating early perturbations in insulin and corticosterone homeostasis. Although these results suggest that tumor necrosis factor plays a significant role in mediating the changes in protein turnover and hormone levels elicited by tumor growth, the inability of such treatment to prevent a reduction in body weight implies that other mediators or tumor-related events were also involvedThis publication has 41 references indexed in Scilit:
- Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Newly identified factors that alter host metabolism in cancer cachexiaTrends in Pharmacological Sciences, 1990
- Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines.Journal of Clinical Investigation, 1988
- Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue.Journal of Clinical Investigation, 1988
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.The Journal of Experimental Medicine, 1988
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- Polypetide mediator networkNature, 1987
- Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.Journal of Clinical Investigation, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Inhibition of basal protein degradation in rat embryo fibroblasts by cycloheximide: Correlation with activities of lysosomal proteasesJournal of Cellular Physiology, 1978